Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20 - LIMN News | RalliesLiminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20
L
LIMN• Reverse split details
- Liminatus Pharma will execute a 1-for-50 reverse stock split of its common stock effective at the Aug. 20 close.
- Shares are expected to trade on a split-adjusted basis on Nasdaq under LIMN at the Aug. 21 open.
- Outstanding shares would fall from 67,160,362 to about 1,343,208 on a pro forma July 2 basis.
- Fractional shares will be rounded up to the nearest whole share.
- New post-split CUSIP: 53271X 207.
•
